These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15057641)

  • 1. Huntington's disease: which drugs might help patients?
    Hannan AJ
    IDrugs; 2004 Apr; 7(4):351-8. PubMed ID: 15057641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.
    van Dellen A; Grote HE; Hannan AJ
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1007-19. PubMed ID: 16445565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drug therapies in Huntington's disease.
    Mason SL; Barker RA
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):273-97. PubMed ID: 19453283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
    Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and environmental factors in the pathogenesis of Huntington's disease.
    van Dellen A; Hannan AJ
    Neurogenetics; 2004 Feb; 5(1):9-17. PubMed ID: 14745585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
    Nithianantharajah J; Hannan AJ
    Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging chemotherapeutic strategies for Huntington's disease.
    Ryu H; Ferrante RJ
    Expert Opin Emerg Drugs; 2005 May; 10(2):345-63. PubMed ID: 15934871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options for Huntington's disease.
    Grimbergen YA; Roos RA
    Curr Opin Investig Drugs; 2003 Jan; 4(1):51-4. PubMed ID: 12625029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
    Wong HK; Bauer PO; Kurosawa M; Goswami A; Washizu C; Machida Y; Tosaki A; Yamada M; Knöpfel T; Nakamura T; Nukina N
    Hum Mol Genet; 2008 Oct; 17(20):3223-35. PubMed ID: 18658163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors as therapeutics for polyglutamine disorders.
    Butler R; Bates GP
    Nat Rev Neurosci; 2006 Oct; 7(10):784-96. PubMed ID: 16988654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of disease: Histone modifications in Huntington's disease.
    Sadri-Vakili G; Cha JH
    Nat Clin Pract Neurol; 2006 Jun; 2(6):330-8. PubMed ID: 16932577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
    Browne SE
    Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.
    Wright DJ; Renoir T; Gray LJ; Hannan AJ
    Adv Neurobiol; 2017; 15():93-128. PubMed ID: 28674979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat.
    Winkler C; Gil JM; Araújo IM; Riess O; Skripuletz T; von Hörsten S; Petersén A
    Brain Res Bull; 2006 Apr; 69(3):306-10. PubMed ID: 16564426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease.
    Grove M; Vonsattel JP; Mazzoni P; Marder K
    Sci Aging Knowledge Environ; 2003 Oct; 2003(43):dn3. PubMed ID: 14586062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal electrical properties of hippocampal neurons modelling early Huntington disease pathogenesis.
    Shelbourne P; Coote E; Dadak S; Cobb SR
    Brain Res; 2007 Mar; 1139():226-34. PubMed ID: 17291464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
    Ribchester RR; Thomson D; Wood NI; Hinks T; Gillingwater TH; Wishart TM; Court FA; Morton AJ
    Eur J Neurosci; 2004 Dec; 20(11):3092-114. PubMed ID: 15579164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of Huntington's disease.
    Gárdián G
    Ideggyogy Sz; 2006 Nov; 59(11-12):396-9. PubMed ID: 17203874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.